Cargando…
Multimodal treatments for resectable esophagogastric junction cancer: a systematic review and network meta-analysis
BACKGROUND: Currently, preoperative chemoradiotherapy, perioperative chemotherapy and preoperative chemotherapy are recommended by NCCN, ESMO and Japanese guidelines respectively for resectable esophageal and junctional cancer. However, these recommendations are mainly based on esophageal cancer res...
Autores principales: | Cheng, Ji, Cai, Ming, Shuai, Xiaoming, Gao, Jinbo, Wang, Guobin, Tao, Kaixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446435/ https://www.ncbi.nlm.nih.gov/pubmed/31044021 http://dx.doi.org/10.1177/1758835919838963 |
Ejemplares similares
-
First-line systemic therapy for advanced gastric cancer: a systematic
review and network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2019) -
Clinical significance of signet ring cells in surgical esophageal and esophagogastric junction adenocarcinoma: A systematic review and meta-analysis
por: Wang, Yi-Fan, et al.
Publicado: (2021) -
Homeobox protein CDX2 as a prognostic biomarker in solid malignancies: a meta-analysis
por: Yuan, Jingsheng, et al.
Publicado: (2017) -
Comparative efficacy and tolerability of adjuvant systemic treatments against resectable colon cancer: a network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2020) -
Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis
por: Jiang, Wen, et al.
Publicado: (2017)